
CV
Healthcare · Medical Devices · $323.3M market cap
$6.06-0.21 (-3.3%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | After the close | -0.15 | -0.15 | 0.0% |
| Aug 13, 2026 | After the close | -0.13 | -0.15 | -15.4% |
| May 14, 2026 | After the close | -0.13 | -0.15 | -15.4% |
| Mar 26, 2026 | After the close | -0.14 | -0.16 | -12.7% |
| Nov 13, 2025 | After the close | -0.12 | -0.17 | -41.7% |
| Aug 14, 2025 | After the close | -0.11 | -0.10 | +9.1% |
| May 28, 2025 | Time not confirmed | — | -2.49 | — |
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well…